Results 141 to 150 of about 304,971 (157)
Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort [PDF]
Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a ...
Daniel H Solomon +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
European Journal of Orthopaedic Surgery and Traumatology, 2021
Surasak Jitprapaikulsarn +2 more
exaly
Surasak Jitprapaikulsarn +2 more
exaly
A fatigue loading model for investigation of iatrogenic subtrochanteric fractures of the femur
Clinical Biomechanics, 2013Jay Bensusan +2 more
exaly
Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
New England Journal of Medicine, 2010Douglas C Bauer +2 more
exaly
Bisphosphonates and atypical subtrochanteric fractures of the femur
Bone and Joint Research, 2017Vikas Khanduja
exaly

